Moody Aldrich Partners LLC Chemo Centryx, Inc. Transaction History

Moody Aldrich Partners LLC

$503 Million
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 04, 2021	SELL	$9.59 - $50.88 $343,322 - $1.82 Million	-35,800 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$49.53 - $68.4 $31,699 - $43,776	640 Added 1.82%	35,800 $1.83 Million
Q4 2020 Feb 16, 2021	BUY	$47.25 - $65.16 $692,732 - $955,310	14,661 Added 71.52%	35,160 $2.18 Million
Q3 2020 Nov 12, 2020	BUY	$46.35 - $61.69 $950,128 - $1.26 Million	20,499 New	20,499 $1.12 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.